These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7606718)

  • 1. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.
    Negrini M; Rasio D; Hampton GM; Sabbioni S; Rattan S; Carter SL; Rosenberg AL; Schwartz GF; Shiloh Y; Cavenee WK
    Cancer Res; 1995 Jul; 55(14):3003-7. PubMed ID: 7606718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
    Nagai H; Negrini M; Carter SL; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
    Cancer Res; 1995 Apr; 55(8):1752-7. PubMed ID: 7712484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region.
    di Iasio MG; Calin G; Tibiletti MG; Vorechovsky I; Benediktsson KP; Taramelli R; Barbanti-Brodano G; Negrini M
    Oncogene; 1999 Feb; 18(8):1635-8. PubMed ID: 10102634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach.
    Baffa R; Negrini M; Mandes B; Rugge M; Ranzani GN; Hirohashi S; Croce CM
    Cancer Res; 1996 Jan; 56(2):268-72. PubMed ID: 8542579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.
    Hampton GM; Mannermaa A; Winqvist R; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee WK; Evans GA
    Cancer Res; 1994 Sep; 54(17):4586-9. PubMed ID: 8062246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.
    Winqvist R; Mannermaa A; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee W
    Cancer Res; 1993 Oct; 53(19):4486-8. PubMed ID: 8402619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.
    Davis M; Hitchcock A; Foulkes WD; Campbell IG
    Cancer Res; 1996 Feb; 56(4):741-4. PubMed ID: 8631007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
    Tran YK; Newsham IF
    Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
    Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S
    Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer.
    Pulido HA; Fakruddin MJ; Chatterjee A; Esplin ED; Beleño N; Martinez G; Posso H; Evans GA; Murty VV
    Cancer Res; 2000 Dec; 60(23):6677-82. PubMed ID: 11118052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at 11q22-q23 in breast cancer.
    Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
    Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23.
    Monaco C; Negrini M; Sozzi G; Veronese ML; Vorechovsky I; Godwin AK; Croce CM
    Genomics; 1997 Dec; 46(2):217-22. PubMed ID: 9417908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
    Koreth J; Bakkenist CJ; McGee JO
    Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and cloning in yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer.
    Hoggard N; Hey Y; Brintnell B; James L; Jones D; Mitchell E; Weissenbach J; Varley JM
    Genomics; 1995 Nov; 30(2):233-43. PubMed ID: 8586422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer.
    Wang SS; Virmani A; Gazdar AF; Minna JD; Evans GA
    Genes Chromosomes Cancer; 1999 Jun; 25(2):154-9. PubMed ID: 10337999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions.
    Karnik P; Chen P; Paris M; Yeger H; Williams BR
    Oncogene; 1998 Jul; 17(2):237-40. PubMed ID: 9674708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.
    Lin JC; Scherer SW; Tougas L; Traverso G; Tsui LC; Andrulis IL; Jothy S; Park M
    Oncogene; 1996 Nov; 13(9):2001-8. PubMed ID: 8934547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss and gain of distinct regions of chromosome 1q in primary breast cancer.
    Bièche I; Champème MH; Lidereau R
    Clin Cancer Res; 1995 Jan; 1(1):123-7. PubMed ID: 9815894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis.
    Gabra H; Watson JE; Taylor KJ; Mackay J; Leonard RC; Steel CM; Porteous DJ; Smyth JF
    Cancer Res; 1996 Mar; 56(5):950-4. PubMed ID: 8640783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.